Semaglutide in TTM Recruitment |
Welcome
Thank you very much for your interest in our study. We are attempting to evaluate the efficacy and safety of semaglutide (Wegovy) in individuals with trichotillomania, otherwise known as hair pulling disorder. The study is being conducted by Dr. Jon Grant at the University of Chicago and involves 10 weekly visits over 9 weeks at the University of Chicago. Participants will be compensated for their time and travel. The information you provide here will be kept confidential and will not be used for purposes other than seeing if you are eligible to participate in the study. If you have additional questions, please call 773-702-5523.